美股市场个股详情
UCBJY UCB S.A. UNSP ADR EACH REPR 0.5 ORD
- 64.865
- -0.705-1.08%
延时15分钟行情收盘价 05/03 15:55 (美东)
246.20亿总市值68.71市盈率TTM
65.260最高价64.784最低价5447股成交量65.230今开65.570昨收35.41万成交额0.00%换手率68.71市盈率(静)3.80亿总股本66.98052周最高2.57市净率246.20亿流通值34.47352周最低0.73股息TTM3.80亿流通股66.980历史最高1.12%股息率TTM0.73%振幅31.963历史最低65.011平均价1股每手
UCB S.A. UNSP ADR EACH REPR 0.5 ORD股票讨论区
登录发表评论
Making sure gains?
Does anyone else think of investing in this way? See what good news might move the markets that day, invest in a bunch of companies, treat it like a portfolio. Trying this today with $药品制造商 - 一般(BK2428.US$ stocks:
$辉瑞(PFE.US$Plaxovid results against omicron may push it up
$EQRx(EQRX.US$Meeting phase III endpoints for sugemabalib
$阿斯利康(AZN.US$Details of the HIMALAYA study showing 22% OS benefit in liver cancer
$UCB S.A. UNSP ADR EACH REPR 0.5 ORD(UCBJY.US$Bimzelx achiev...
$辉瑞(PFE.US$Plaxovid results against omicron may push it up
$EQRx(EQRX.US$Meeting phase III endpoints for sugemabalib
$阿斯利康(AZN.US$Details of the HIMALAYA study showing 22% OS benefit in liver cancer
$UCB S.A. UNSP ADR EACH REPR 0.5 ORD(UCBJY.US$Bimzelx achiev...
1
4
暂无评论
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅
bic mutney : buy more
Dafydd Green楼主 : Might test the theory and see if it works… The market moves in mysterious ways, Cardiff Oncology (CRDF) had great data out yesterday and slumped, never quite know how markets take this kind of news (e.g. maybe people are looking at the data and thinking “well it’s good but it’s not great”)
Dafydd Green楼主 : Eventually $Atara Biotherapeutics (ATRA.US)$ went up 2.08% but the worst was $EQRx (EQRX.US)$ going down 13.54%… Note to self - investigate why that would have been (strength of trial data? Competitive market for KRAS+ CRC? I.e. not so many people and actually quite a lot of drugs, and OS that’s not so special at 9months)
Evil_Monkey : You have to buy the rumor and sell the news. Once it hits the news, you should have already sold.